Market Report: Stand-out performer Avanti soars 20.25p
Thursday 20 February 2014
After a roller-coaster ride for investors in the Aim-listed satellite operator Avanti Communications this year, news of a deal with the telecoms giant Vodafone called it up nearly 10 per cent higher.
Avanti agreed a three-year contract to supply 3G services to a Vodafone subsidiary in Europe.
Toby Morris, senior sales trader at CMC Markets, said: “Avanti was the stand-out performer. The move may well have been magnified by the stock’s performance so far in 2014, which prior to this had them down near 20 per cent.”
Avanti soared 20.25p to 225.25p.
Vodafone is embarking on a share consolidation – investors will receive six new shares for every existing 11 Vodafone shares – as it announced they will receive around 102p a share after it sold its stake in the US group Verizon Wireless for $130bn (£78bn).
Vodafone eased 0.65p to 223.35p.
The wider market was lacklustre. The FTSE 100 edged up just 0.28 points to 6796.71.
Investors were hoping a smart new website would mean smarter sales and profits at Marks & Spencer. Jefferies, which raised its rating to buy, said the new website is now “industry-leading” and gave M&S a 480p price target, up from 600p for shares that were 4.7p better at 501p.
AstraZeneca was bottom of the pile, dragged down largely by going ex-dividend. But investors also lost interest in the pharmaceutical giant after news that the Dublin-based drugs maker Actavis bought New York’s Forest Laboratories in a $25bn deal. Some punters had hoped Astra would buy the group and it fell 105.5p to 3,987p.
Mid-tier listed hedge fund Man Group was reported to be on the hunt to buy another asset-management business but eased 0.25p to 83.25p.
The online-trading platform Plus500 announced its maiden results. Liberum Capital, the house broker, upped its price target to 500p (from 275p) and it advanced 90.5p to 425p.
Aim-listed Allergy Therapeutics got approval of a clinical trial application for its allergic rhinitis product by Health Canada, the Canadian health authority, and was 1.125p healthier at 14.25p.
- 2 Smartphones are making children borderline autistic, says psychiatrist
- 3 Why this father didn’t hide his daughter’s heroin overdose in her obituary
- 4 Company breaks open Apple Watch to discover what it says is 'planned obsolescence'
Smartphones are making children borderline autistic, says psychiatrist
Nepal earthquake: More than 1,100 killed across four countries and in Mount Everest avalanche
Nepal earthquake: The race is on to help thousands trapped under rubble around Kathmandu, while remote villages face a long wait for help
Royal baby: Live updates as superbug closes ward at St Mary's Hospital where Duchess of Cambridge is due to give birth
Teaching profession headed for crisis as numbers continue to drop and working lives become 'unbearable'
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband
The sickening truth about food banks that the Tories don't want you to know
Migrant boat disaster: Ukip candidate mocks victims in sickening Twitter post
Nigel Farage wants the BBC to stop making programmes like Doctor Who, Strictly Come Dancing, and Top Gear
Global warming: Scientists say temperatures could rise by 6C by 2100 and call for action ahead of UN meeting in Paris
Rupert Murdoch berated Sun journalists for not doing enough to attack Ed Miliband and stop him winning the general election
iJobs Money & Business
£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...
£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...
£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...